Saturday, February 16, 2019
    Latest

    Multiple Sclerosis

    Home Multiple Sclerosis
    Multiple Sclerosis

    PriceWatch: MS Drug Costs May Skyrocket For Medicare Beneficiaries

    0
    MS
    Multiple Sclerosis

    Study Indicates Stem Cell Relapsing MS Proves Effective and Safe

    0
    Multiple Sclerosis

    Gut Immune Cells Reduce Multiple Sclerosis Inflammation in Study

    0
    Multiple Sclerosis

    UW-Madison Discovery Introduces Opportunities to Slow or Reverse Multiple Sclerosis

    0
    Multiple Sclerosis

    QIMR Berghofer Australia Discovers New Immunotherapy Improves MS Symptoms

    0
    Multiple Sclerosis

    National Neurological Conditions Surveillance System Open up Parkinson’s Research Opportunities

    0
    Multiple Sclerosis

    German Merck KGaA and Multiple Sclerosis Group ACP Advance Patient Focused...

    0
    Multiple Sclerosis

    Novartis Announces FDA and EMA Filing Acceptance of Siponimod

    0
    Multiple Sclerosis

    Academic Med Center Assessments Impact Networks on MS Patient Outcomes

    0
    Multiple Sclerosis

    Mass General Hospital Study: Link Between GI Distress and Onset of...

    0
    12Page 1 of 2
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved